HIV-1 disease progression and mortality before the introduction of highly active antiretroviral therapy in rural Uganda.

Lieve Van der PaalHeiner Grosskurth


To provide estimates of survival and progression to different HIV disease endpoints after HIV infection among adults in a rural Ugandan setting. A prospective population-based cohort study. Eligible individuals at least 15 years of age with documented HIV seroconversion were recruited from a general population cohort in rural Uganda, along with a randomly selected proportion of HIV-prevalent and HIV-negative individuals. All participants were followed up every 3 months, and CD4 cell counts taken every 6 months in HIV-positive participants. Life tables and Kaplan-Meier functions were used to estimate survival patterns for all endpoints [death, time to World Health Organization (WHO) stage 2, 3, AIDS and CD4 cell count < 200 cells/mul]. Analysis of follow-up time was truncated when antiretroviral therapy (ART) became available in the area in January 2004. We recruited 240 HIV incident cases, 108 prevalent cases and 257 HIV-negative controls. Crude mortality rates were 70.0 per 1000 person-years in HIV-positive, and 12.1 per 1000 person-years in HIV-negative individuals. The median time from seroconversion to death was 9.0 years (N = 240) and 6.2 years to a CD4 cell count less than 200 cells/mul or WHO stage 4 (N = 229). The media...Continue Reading


Mar 1, 1995·The Journal of Infectious Diseases·O A AnzalaF A Plummer
Nov 21, 2000·Lancet·R De Lancie
Nov 21, 2000·Lancet·P H KilmarxT D Mastro
Jan 26, 2002·BMJ : British Medical Journal·Dilys MorganJames A G Whitworth
Feb 8, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Roger SalamonLuc Montagnier
Apr 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ram RangsinKenrad E Nelson
Apr 6, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ludo LavreysJulie Overbaugh

❮ Previous
Next ❯


Mar 24, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·R Rosenbrock, A J Schmidt
Jul 25, 2008·Sexually Transmitted Infections·P D GhysG P Garnett
Jan 10, 2014·PloS One·Rebecca N NsubugaLeigh Anne Shafer
Oct 5, 2010·PLoS Pathogens·Rebecca S RudicellMichael L Wilson
Mar 4, 2009·Sexual Health·John M MurrayMatthew G Law
Jan 31, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roger YingBrian G Williams
Oct 30, 2012·The Journal of Infection·Joris Hemelaar
Feb 12, 2009·Tropical Medicine & International Health : TM & IH·S NakibingeJ Seeley
May 17, 2014·Statistics in Medicine·Severin Guy MahianeBertran Auvert
Sep 5, 2015·Phytotherapy Research : PTR·Walter ChingwaruPetrina T Kapewangolo
Sep 2, 2016·Pharmaceutical Statistics·Tarylee ReddyMarc Aerts
Sep 17, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara LodiUNKNOWN CASCADE Collaboration in EuroCoord
Jul 17, 2019·Pharmaceutical Statistics·Tarylee ReddyGeert Willem Schurink
Oct 27, 2020·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lily GeidelbergMarie-Claude Boily
Oct 28, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Athena P KourtisUNKNOWN Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.